Pathos develops an AI-enabled drug discovery platform to reduce the medication development process. Its self-learning platform utilizes big data, technology, and artificial intelligence to identify targets, validate them, and establish their clinical efficacy. It also helps drug developers to explore novel concepts, and advance breakthroughtherapies. The company's OS platform is capable of managing the entire end-to-end process of designing and developing novel therapeutics.

AI/ML

Biotechnology

Data

Health Care

Pathos

The New York City office focuses on translational biology, computational research, and leadership in precision medicine.

People (9)

Jobs (0)

Other offices